SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-046705
Filing Date
2019-12-23
Accepted
2019-12-23 16:01:37
Documents
12
Period of Report
2019-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K srpt-8k_20191221.htm   iXBRL 8-K 49673
  Complete submission text file 0001564590-19-046705.txt   183672

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA srpt-20191221.xsd EX-101.SCH 6012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20191221_lab.xml EX-101.LAB 19493
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20191221_pre.xml EX-101.PRE 11663
9 EXTRACTED XBRL INSTANCE DOCUMENT srpt-8k_20191221_htm.xml XML 3558
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 191305948
SIC: 2834 Pharmaceutical Preparations